Please enter subscribe form shortcode

2025

  1. Swingle, K. L., Hamilton, A. G., Safford, H. C., Geisler, H. C., Thatte, A. S., Palanki, R., Murray, A. M., Han, E. L., Mukalel, A. J., Han, X., Palanki, R., Joseph, R. A., Ghalsasi, A. A., Alameh, M.-G., Weissman, D., Mitchell, M.J. (2025). Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia. Nature.

  1. Safford, H.C., Shuler, C. F., Geisler, H. C., Thatte, A. S., Swingle, K. L., Han, E. H., Murray, A. M., Hamilton, A. G., Yamagata, H., Mitchell, M. J. (2025). Probing the role of lipid nanoparticle elasticity on mRNA delivery to the placenta. Nano Letters.

  1. Xue, L., Swingle, K. L., Mitchell, M. J. (2025). Small structural changes in siloxane-based lipidoids improve tissue-specific mRNA delivery. Nature Nanotechnology.

  1. Xue, L.*, Zhao, G.*, Gong, N.*, Han, X., Shepherd, S. J., Xiong, X. Xiao, Z., Palanki, R., Xu, J., Swingle, K. L., Warzecha, C. C., El-Mayta, R., Chowdhary, V., Yoon, I.-C., Xu, J., Cui, J., Shi, Y., Alameh, M.-G., Wang, K., Wang, L., Pochan, D. J., Weissman, D., Vaughan, A. E., Wilson, J. M., Mitchell, M. J. (2025). Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery. Nature Nanotechnology.

2024

  1. Han, E. L., Tang, S., Kim, D., Murray, A. M., Swingle, K. L., Hamilton, A. G., Mrksich, K., Padilla M. S., Palanki, R., Li, J. J., Mitchell, M. J. (2024). Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain. Nano Letters.

  1. Han, X., Alameh, M.-G., Xu, Y., Palanki, R., El-Mayta, R., Dwivedi, G., Swingle, K. L., Xu, J., Gong, N., Xue, L., Shi, Q., Yoon, I.-C., Warzecha, C. C., Wilson, J. M., Weissman, D., Mitchell, M. J. (2024). Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution. Nature Biomedical Engineering.

  1. Swingle, K. L., Hamilton, A. G., Mitchell, M. J. (2024). Flow cytometric analysis of the murine placenta to evaluate nanoparticle platforms during pregnancy. Placenta.

  1. Palanki, R.*, Riley, J. S.*, Bose, S. K., Luks, V., Dave, A., Kus, N., White, B. M., Ricciardi, A. S., Swingle, K. L., Xue, L., Sung, D., Thatte, A. S., Safford, H. C., Chaluvadi, V. S., Carpenter, M., Han, E. L., Maganti, R., Hamilton, A. G., Mrksich, K., Billingsley, M. M., Zoltick, P., Alameh, M.-G., Weissman, D., Mitchell, M. J., Peranteau, W. H. (2024). In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells. Proceedings of the National Academy of Sciences.

  1. Palanki, R., Han, E. L., Murray, A. M., Maganti, R., Tang, S., Swingle, K. L., Kim, D., Yamagata, H., Safford, H. C., Mrksich, K., H. C., Peranteau, W. H., Mitchell, M. J. (2024). Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing. Lab on a Chip.

  1. Geisler, H. C., Ghalsasi, A. A., Safford, H. C., Swingle, K. L., Thatte, A. S., Mukalel, A. J., Gong, N., Hamilton, A. G., Han, E. L., Nachod, B. E., Padilla, M. S., Mitchell, M. J. (2024). EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta. Journal of Controlled Release.

  1. Hamilton, A. G., Swingle, K. L., Thatte, A. S., Mukalel, A. J., Safford, H. C., Billingsley, M. M., El-Mayta, R., Han, X., Nachod, B. E., Joseph, R. A., Metzloff, A. E., Mitchell, M. J. (2024). High-throughput in vivo screening identifies differential influences on mRNA LNP immune cell delivery by administration route. ACS Nano.

  1. Billingsley, M. M., Gong, N., Mukalel, A. J., Thatte, A. S., El-Mayta, R., Patel, S. K., Metzloff, A. E., Swingle, K. L., Han, X., Xue, L., Hamilton, A. G., Safford, H. C., Alameh, M.-G., Papp, T., Parhiz, H., Weissman, D., Mitchell, M. J. (2024). In vivo CAR T cell engineering via targeted lipid nanoparticles with extrahepatic tropism. Small.

2023

  1. Thatte, A. S., Hamilton, A. G., Nachod, B. E., Mukalel, A. J., Billingsley, M. M., Palanki, R., Swingle, K. L., Mitchell, M. J. (2023). mRNA lipid nanoparticles for ex vivo engineering of immunosuppressive T cells for autoimmunity therapies. Nano Letters.

  1. Hamilton, A. G., Swingle, K. L., Joseph, R. A., Mai, D., Gong, N., Billingsley, M. M., Alameh, M.-G., Weissman, D., Sheppard, N. C., June, C. H., Mitchell, M. J. (2023). Ionizable lipid nanoparticles with integrated immune checkpoint inhibition for mRNA CAR T cell therapy. Advanced Healthcare Materials.

  1. Safford, H. C., Swingle, K. L., Geisler, H. C., Hamilton, A. G., Thatte, A. S., Ghalsasi, A. A., Billingsley, M. M., Alameh, M.-G., Weissman, D., Mitchell, M. J. (2023). Orthogonal design of experiments for engineering of lipid nanoparticles for mRNA delivery to the placenta. Small.

  1. Palanki, R.*, Bose, S. K.*, Dave, A., White, B. M., Berkowitz, C., Luks, V., Yaqoob, F., Han, E., Swingle, K. L., Menon, P., Hodgson, E., Biswas, A., Billingsley, M. M., Li, L., Yiping, F., Carpenter, M., Trokhan, A., Yeo, J., Johana, N., Wan, Wan, T. Y., Alameh, M.-G., Zoltick, P., Bennett, F., Storm, P., Jain, R., Chan, J., Weissman, D., Mitchell, M. J., Peranteau, W. H. (2023). Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease. ACS Nano.

  1. Swingle, K. L., Ricciardi, A. S., Peranteau, W. H., & Mitchell, M. J. (2023). Delivery technologies for women’s health applications. Nature Reviews Bioengineering.

  1. Hamilton, A. G.*, Swingle, K. L.*, Mitchell, M. J. (2023). Biotechnology: overcoming biological barriers to nucleic acid delivery using lipid nanoparticles. PLoS Biology.

  1. Swingle, K. L., Safford, H. C., Geisler, H. C., Hamilton, A. G., Thatte, A. S., Billingsley, M. M., Joseph, R. A., Mrksich, K., Padilla, M. S., Ghalsasi, A. A., Alameh, M.-G., Weissman, D., & Mitchell, M. J. (2023). Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy. Journal of the American Chemical Society.

  1. Bashiri, G., Padilla, M. S., Swingle, K. L., Shepherd, S. J., Mitchell, M. J., Wang, K. (2023). Nanoparticle protein corona: from structure and function to therapeutic targeting. Lab on a Chip.

2022

  1. Palanki, R.*, Swingle, K. L.*, Mitchell, M. J. (2022). A (controlled) spill of IL2 for localized treatment of mesothelioma. Clinical Cancer Research.

  1. Patel, S. K., Billingsley, M. M., Frazee, C., Han, X., Swingle, K. L., Qin, J., Alameh, M.-G., Wang, K., Weissman, D., Mitchell, M. J. (2022). Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.

  1. Sekhon, U. D. S., Swingle, K.L., Girish, A., Luc, N., de la Fuente, M., Alvikas, J., Haldeman, S., Hassoune, A., Shah, K., Kim, Y., Eppell, S., Capadona, J., Shoffstall, A., Neal, M. D., Li, W., Nieman, M., Sen Gupta, A. (2022). Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding. Science Translational Medicine.

  1. Qin, J., Xue, L., Gong, N., Zhang, H., Shepherd, S. J., Haley, R.M., Swingle, K.L., Mitchell, M. J. (2022). RGD peptide-based lipids for targeted mRNA delivery and gene editing applications. RSC Advances.

  1. Swingle, K. L., Billingsley, M. M., Bose, S. K., White, B., Palanki, R., Dave, A., Patel, S. K., Gong, N., Hamilton, A. G., Alameh, M.-G., Weissman, D., Peranteau, W. H., Mitchell, M. J. (2022). Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery. Journal of Controlled Release.

  1. Han, X., Zhang, H., Butowska, K., Swingle, K. L., Alameh, M.-G., Weissman, D., Mitchell, M. J. (2021). An ionizable lipid toolbox for RNA delivery. Nature Communications.

  1. Billingsley, M. M., Hamilton, A. G., Mai, D., Patel, S. K., Swingle, K. L., Sheppard, N. C., June, C. H., Mitchell, M. J. (2022). Orthogonal design of experiments for optimization of lipid nanoparticles for mRNA engineering of CAR T cells. Nano Letters.

2021

  1. Swingle, K. L.*, Hamilton, A. G.*, Mitchell, M. J. (2021). Lipid nanoparticle-mediated delivery of mRNA therapeutics and vaccines. Trends in Molecular Medicine.